Investment Stage: Series B
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 14.07.2025 | Illimis Th... | illimistx.com | $42M | South Kore... |
Mentions in press and media 3
| Date | Title | Description |
| 14.07.2025 | Illimis Therapeutics Raises $42M in Series B Funding | Illimis Therapeutics, a Seoul, South Korea-based biotechnology company which specializes in central nervous system and immune-related diseases, raised $42M in Series B funding. Backers included DSC Investment, Woori Venture Partners, Korea ... |
| 14.07.2025 | Illimis Therapeutics Closes 58 billion KRW ($42 million) Series B Financing to accelerate CNS and Immune Disease Drug Development via GAIA Platform | Validates technological prowess of GAIA platform and intensifies global co-development effort, including the existing partnership with Lilly Catalyze360-ExploR&D Funds to accelerate Alzheimer's and immune disease drug development, expan... |
| 18.11.2020 | 10 Korean Startups That Shined in 2020 | With the year slowly coming to a close, let’s take a look back at how ten South Korean startups in 2020 overcame challenges such as COVID-19 and how they changed gears to adapt to the new normal in business and everyday life. It’s been a di... |